Investors & Media

Overview

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Stock Quote
FLKS (Common Stock)
Price & Exchange$3.44 (US Dollar)
NASDAQ GS
Change (%) Stock is Down 0.16 (4.44%)
Volume56,293
Data as of 09/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast
Flex Pharma Inc at the Cantor Fitzgerald 2017 Global Healthcare Conference (Live)
09/25/17 at 3:35 p.m. ET
Flex Pharma Inc at the Cantor Fitzgerald 2017 Global Healthcare Conference
Monday, September 25, 2017 3:35 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Upcoming EventsMore >>
DateTitle
09/25/17 3:35 p.m. ET
Flex Pharma Inc at the Cantor Fitzgerald 2017 Global Healthcare Conference
Data Provided by Thomson Reuters